---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-26-000008"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2026-02-10T23:59:59+00:00"
generated_at: "2026-05-16T03:35:39.301934+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Oscar Health reports record 3.4M members, FY2025 net loss $443M; guides FY2026 revenue $18.7-$19B

## Summary
- Full-year 2025 net loss $443.2M ($1.69 diluted EPS) vs prior-year net income $25.4M ($0.10 diluted EPS).
- Record membership of ~3.4 million as of Dec 31, 2025, up from 1.68 million a year earlier.
- FY2025 total revenue $11.7B (up 27% YoY); medical loss ratio 87.4% (vs 81.7% in 2024).
- FY2026 guidance: revenue $18.7-$19.0B, MLR 82.4-83.4%, SG&A ratio 15.8-16.3%, operating earnings $250-$450M.
- Entered into $475M secured three-year revolving credit facility (Feb 6, 2026) for general corporate purposes.

## SEC filing metadata
- accession: 0001568651-26-000008
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2026-02-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000008/0001568651-26-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000008/oscr-20260206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-26-000008
- JSON: https://secwatch.observer/filing/0001568651-26-000008.json
- Plain text: https://secwatch.observer/filing/0001568651-26-000008.txt

## Source-grounded claims
- claim_id: 1d2c9301f1cec561f2e15a55f6b3bd93cbed631e
  claim: Oscar Health, Inc. incurred revolving credit of $475.0 million with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto at Term SOFR plus a margin of 4.50% per annum, or the Alternate Base Rate plus a ma maturing February 6, 2029.
  evidence_excerpt: On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000008/0001568651-26-000008-index.htm
- claim_id: d91847d22dde1b9ecf301253c9d7604745366911
  claim: Oscar Health, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto valued at $475.0 million (effective 2026-02-06).
  evidence_excerpt: On February 6, 2026, Oscar Health, Inc. (the “Company”), entered into a $475.0 million secured three-year revolving credit facility (the “Revolving Credit Facility”), pursuant to a Credit Agreement (the “Credit Agreement”), by and among the Company, certain subsidiaries of the Company, as subsidiary guarantors, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000008/0001568651-26-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.